British medical equipment company Cirdan raises £2.3M to expand operations

Cirdan designs, manufactures and supplies innovative software and imaging solutions for the acceleration and enhancement of diagnosis. Its systems are optimised for pathology and clinical laboratory usage. Cirdan’s primary product is its world-class Laboratory Information System, ULTRA. ULTRA has been designed to streamline laboratory operations and is currently installed in more than 72 laboratories across 6 continents. Another core product is PathLite Compact, a purpose-built system designed specifically for gross imaging within clinical laboratories. Here are details of Cirdan‘s latest funding round :

🚀 Launch


🏭 Industry

Medical equipment


Dr. Hugh Cormican (CEO), Stephen Dunniece (Chief Officer Imaging), Laura Henry (Head of Finance), Philip Moore (Head of Sales), Donald MacKerracher (CIO), Rebecca Fitton (Marketing), Paul Matthews (Head of QARA), Martin McCrystal (Head of Engineering ULTRA), Dominic Saunders (Head of Customer Support), Kevin Neil (Operations & CO Path XL)

💸 Funding & Investors

INVESTMENT (October 2023)£2.3 million
INVESTORS (October 2023)led by Kernel Capital through the Bank of Ireland Kernel Capital Growth Fund (NI). Other investors include Clarendon Fund Managers and high net worth private investors.

🎯 Funding purpose

Expand business operations with the creation of up to 25 new jobs ahead of new contract wins. 

🌐 Country HQ

UK (Lisburn)

Leave a Reply

Your email address will not be published.